EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

sFlt-1/PlGF Ratio as a Central Biomarker for Preeclampsia and Perinatal Outcomes: A Multisystem Retrospective Cohort Study

Anca Tătaru-Copos, Anca Carmen Huniadi, Rodica Georgeta Negrini, Mircea Ioachim Popescu iD, Paula Trif, Gelu Florin Murvai, Radu Galiș iD, Cristian Sava iD, Florin Szasz, Romina Viorela Murvai

Journal of Clinical Medicine · 05.03.2026 · 15 (5) · 1990

DOI: 10.3390/jcm15051990 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.03.2026. Verfasst von Anca Tătaru-Copos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Biological and Biomedical Sciences, University of Oradea, 1 University Street, 410087 Oradea, Romania. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oradea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preeclampsia is a major cause of maternal and perinatal morbidity, characterized by placental dysfunction and angiogenic imbalance. The soluble fms-like tyrosine kinase-1-to-placental growth factor (sFlt-1/PlGF) ratio has emerged as a promising biomarker for preeclampsia; however, its prognostic value for maternal and neonatal outcomes remains incompletely defined.

Methods

This retrospective cohort study included 320 pregnant women, of whom 68 were diagnosed with preeclampsia, and 252 served as non-preeclamptic controls. Maternal serum sFlt-1 and PlGF levels were measured after 20 weeks of gestation at the time of clinical evaluation for suspected hypertensive disorders of pregnancy. Group comparisons, effect size analysis, receiver operating characteristic (ROC) curve analysis, and multivariable regression models were used to assess diagnostic performance and associations with maternal and neonatal outcomes.

Results

The sFlt-1/PlGF ratio was significantly higher in women with preeclampsia compared with non-preeclamptic pregnancies (58.5 ± 17.3 vs. 34.6 ± 19.0; p < 0.001; Cohen’s d = 1.31). ROC analysis demonstrated good discriminative ability for preeclampsia (AUC = 0.81, 95% CI: 0.75–0.87), with a high negative predictive value. Increasing sFlt-1/PlGF values were independently associated with earlier gestational age at delivery, lower birth weight, reduced Apgar (Appearance, Pulse, Grimace, Activity, and Respiration) score, and a higher likelihood of neonatal intensive care unit admission.

Conclusions

The sFlt-1/PlGF ratio is a robust biomarker for preeclampsia, providing both diagnostic discrimination and prognostic information regarding maternal and neonatal outcomes. Its integration into clinical practice may support clinical risk awareness when interpreted in the context of standard clinical evaluation and support informed decision-making in pregnancies with suspected or confirmed preeclampsia.

Schlagwörter

Stichwörter der Autor:innen

angiogenic imbalancebiomarkersneonatal outcomesplacental dysfunctionpreeclampsiarisk stratificationsFlt-1/PlGF ratio

Autor:innen und Institutionen

  • Doctoral School of Biological and Biomedical Sciences, University of Oradea, 1 University Street, 410087 Oradea, Romania.
  • Department of Surgical Sciences, Obstetrics and Gynecology, Faculty of Medicine and Pharmacy, University of Oradea, 1 University Street, 410087 Oradea, Romania.
  • Calla-Infertility Diagnostic and Treatment Center, Constantin A. Rosetti Street, 410103 Oradea, Romania.
  • Pelican Clinical Hospital, Corneliu Coposu Street 2, 410450 Oradea, Romania.
  • Department of Obstetrics and Gynecology, Emergency County Hospital Bihor, 65 Gheorghe Doja Street, 410169 Oradea, Romania.
  • Department of Cardiology, Emergency County Hospital Bihor, Emergency County Hospital Bihor, 65 Gheorghe Doja Street, 410169 Oradea, Romania.

ORCID-Profile: Mircea Ioachim Popescu, Radu Galiș, Cristian Sava

Förderung

  • University of Oradea

Zitieren

APA

Tătaru-Copos, A., Huniadi, A. C., Negrini, R. G., Popescu, M. I., Trif, P., Murvai, G. F., Galiș, R., Sava, C., Szasz, F., & Murvai, R. V. (2026). sFlt-1/PlGF Ratio as a Central Biomarker for Preeclampsia and Perinatal Outcomes: A Multisystem Retrospective Cohort Study. Journal of Clinical Medicine, 15(5), 1990. https://doi.org/10.3390/jcm15051990

Vancouver

Tătaru-Copos A, Huniadi AC, Negrini RG, Popescu MI, Trif P, Murvai GF, et al. sFlt-1/PlGF Ratio as a Central Biomarker for Preeclampsia and Perinatal Outcomes: A Multisystem Retrospective Cohort Study. Journal of Clinical Medicine. 2026;15(5):1990. doi:10.3390/jcm15051990

BibTeX
@article{TtaruCopos2026,
  author = {Tătaru-Copos, Anca and Huniadi, Anca Carmen and Negrini, Rodica Georgeta and Popescu, Mircea Ioachim and Trif, Paula and Murvai, Gelu Florin and Galiș, Radu and Sava, Cristian and Szasz, Florin and Murvai, Romina Viorela},
  title = {sFlt-1/PlGF Ratio as a Central Biomarker for Preeclampsia and Perinatal Outcomes: A Multisystem Retrospective Cohort Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {1990},
  doi = {10.3390/jcm15051990}
}
Kostenlos starten →